-
1
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
UK Prospective Diabetes Study (UKPDS) Group.
-
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
2
-
-
0029147687
-
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
-
Ohkubo Y, Kishikawa H, Araki E, et al., Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-17.
-
(1995)
Diabetes Res Clin Pract
, vol.28
, pp. 103-117
-
-
Ohkubo, Y.1
Kishikawa, H.2
Araki, E.3
-
3
-
-
33947408052
-
Why, when and how to initiate insulin therapy in patients with type 2 diabetes
-
DOI 10.1111/j.1742-1241.2007.01309.x
-
Tibaldi J, Rakel RE,. Why, when and how to initiate insulin therapy in patients with type 2 diabetes. Int J Clin Pract 2007; 61: 633-44. (Pubitemid 46449825)
-
(2007)
International Journal of Clinical Practice
, vol.61
, Issue.4
, pp. 633-644
-
-
Tibaldi, J.1
Rakel, R.E.2
-
4
-
-
84856623197
-
Comparison of the efficacy of glimepiride, metformin, and rosiglitazone monotherapy in Korean drug-naïve type 2 diabetic patients: The practical evidence of antidiabetic monotherapy study
-
Yoon KH, Shin JA, Kwon HS, et al., Comparison of the efficacy of glimepiride, metformin, and rosiglitazone monotherapy in Korean drug-naïve type 2 diabetic patients: the practical evidence of antidiabetic monotherapy study. Diabetes Metab J 2011; 35: 26-33.
-
(2011)
Diabetes Metab J
, vol.35
, pp. 26-33
-
-
Yoon, K.H.1
Shin, J.A.2
Kwon, H.S.3
-
5
-
-
0022544897
-
Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes
-
Groop LC, Pelkonen R, Koskimies S, et al., Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes. Diabetes Care 1986; 9: 129-33. (Pubitemid 16080466)
-
(1986)
Diabetes Care
, vol.9
, Issue.2
, pp. 129-133
-
-
Groop, L.C.1
Pelkonen, R.2
Koskimies, S.3
-
6
-
-
0036483958
-
Sulfonylurea inadequacy: Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57)
-
DOI 10.2337/diacare.25.2.330
-
Wright A, Burden AC, Paisey RB, et al., Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Diabetes Care 2002; 25: 330-6. (Pubitemid 41079631)
-
(2002)
Diabetes Care
, vol.25
, Issue.2
, pp. 330-336
-
-
Wright, A.1
Burden, A.C.F.2
Paisey, R.B.3
Cull, C.A.4
Holman, R.R.5
-
7
-
-
0025630035
-
Insulin use in NIDDM
-
Genuth S,. Insulin use in NIDDM. Diabetes Care 1990; 13: 1240-64.
-
(1990)
Diabetes Care
, vol.13
, pp. 1240-1264
-
-
Genuth, S.1
-
8
-
-
0024364975
-
Characteristics of non-insulin-dependent diabetic patients with secondary failure to oral antidiabetic therapy
-
Groop L, Schalin C, Franssila-Kallunki A, et al., Characteristics of non-insulin-dependent diabetic patients with secondary failure to oral antidiabetic therapy. Am J Med 1989; 87: 183-90. (Pubitemid 19201640)
-
(1989)
American Journal of Medicine
, vol.87
, Issue.2
, pp. 183-190
-
-
Groop, L.1
Schalin, C.2
Franssila-Kallunki, A.3
Widen, E.4
Ekstrand, A.5
Eriksson, J.6
-
9
-
-
70349939595
-
Practical guidance on intensification of insulin therapy with BIAsp 30: A consensus statement
-
Unnikrishnan AG, Tibaldi J, Hadley-Brown M, et al., Practical guidance on intensification of insulin therapy with BIAsp 30: a consensus statement. Int J Clin Pract 2009; 63: 1571-7.
-
(2009)
Int J Clin Pract
, vol.63
, pp. 1571-1577
-
-
Unnikrishnan, A.G.1
Tibaldi, J.2
Hadley-Brown, M.3
-
10
-
-
0021813187
-
Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
-
DOI 10.1007/BF00280883
-
Matthews DR, Hosker JP, Rudenski AS, et al., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9. (Pubitemid 15018832)
-
(1985)
Diabetologia
, vol.28
, Issue.7
, pp. 412-419
-
-
Matthews, D.R.1
Hosker, J.P.2
Rudenski, A.S.3
-
11
-
-
28444436268
-
Insulin secretory defect plays a major role in the development of diabetes in patients with distal pancreatectomy
-
Lee BW, Kang HW, Heo JS, et al., Insulin secretory defect plays a major role in the development of diabetes in patients with distal pancreatectomy. Metabolism 2006; 55: 135-41.
-
(2006)
Metabolism
, vol.55
, pp. 135-141
-
-
Lee, B.W.1
Kang, H.W.2
Heo, J.S.3
-
12
-
-
61849106040
-
Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels
-
Utzschneider KM, Prigeon RL, Faulenbach MV, et al., Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 2009; 32: 335-41.
-
(2009)
Diabetes Care
, vol.32
, pp. 335-341
-
-
Utzschneider, K.M.1
Prigeon, R.L.2
Faulenbach, M.V.3
-
13
-
-
0029384730
-
The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion
-
Wareham NJ, Phillips DI, Byrne CD, Hales CN,. The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med 1995; 12: 931.
-
(1995)
Diabet Med
, vol.12
, pp. 931
-
-
Wareham, N.J.1
Phillips, D.I.2
Byrne, C.D.3
Hales, C.N.4
-
14
-
-
19444376266
-
Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus
-
DOI 10.1592/phco.2005.25.6.810
-
Eurich DT, Simpson SH, Majumdar SR, Johnson JA,. Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus. Pharmacotherapy 2005; 25: 810-6. (Pubitemid 40727132)
-
(2005)
Pharmacotherapy
, vol.25
, Issue.6
, pp. 810-816
-
-
Eurich, D.T.1
Simpson, S.H.2
Majumdar, S.R.3
Johnson, J.A.4
-
15
-
-
0035340319
-
Insulin secretory dysfunction and insulin resistance in the pathogenesis of korean type 2 diabetes mellitus
-
Kim DJ, Lee MS, Kim KW, Lee MK,. Insulin secretory dysfunction and insulin resistance in the pathogenesis of korean type 2 diabetes mellitus. Metabolism 2001; 50: 590-3.
-
(2001)
Metabolism
, vol.50
, pp. 590-593
-
-
Kim, D.J.1
Lee, M.S.2
Kim, K.W.3
Lee, M.K.4
-
16
-
-
23944458639
-
Heterogeneity of early-onset and ketosis-resistant diabetes in Korean subjects - Is it possible to determine cut-off age of early-onset type 2 diabetes?
-
Lee BW, Kim SY, Kim JY, et al., Heterogeneity of early-onset and ketosis-resistant diabetes in Korean subjects-is it possible to determine cut-off age of early-onset type 2 diabetes? Diabetes Res Clin Pract 2005; 70: 38-45.
-
(2005)
Diabetes Res Clin Pract
, vol.70
, pp. 38-45
-
-
Lee, B.W.1
Kim, S.Y.2
Kim, J.Y.3
-
17
-
-
77956628848
-
Dysfunctional pancreatic beta-cells of critical stress play a more prominent role in the development of stress diabetes in critically burned Korean subjects
-
Byung-Wan L, Jun H, Yim HJ, et al., Dysfunctional pancreatic beta-cells of critical stress play a more prominent role in the development of stress diabetes in critically burned Korean subjects. Metabolism 2010; 59: 1307-15.
-
(2010)
Metabolism
, vol.59
, pp. 1307-1315
-
-
Byung-Wan, L.1
Jun, H.2
Yim, H.J.3
-
18
-
-
80053039032
-
The changes in early phase insulin secretion in newly diagnosed, drug naive korean prediabetes subjects
-
Rhee SY, Kim JY, Chon S, et al., The changes in early phase insulin secretion in newly diagnosed, drug naive korean prediabetes subjects. Korean Diabetes J 2010; 34: 157-65.
-
(2010)
Korean Diabetes J
, vol.34
, pp. 157-165
-
-
Rhee, S.Y.1
Kim, J.Y.2
Chon, S.3
-
19
-
-
23644443235
-
Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: Effects of lifestyle intervention and metformin
-
DOI 10.2337/diabetes.54.8.2404
-
Kitabchi AE, Temprosa M, Knowler WC, et al., Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes 2005; 54: 2404-14. (Pubitemid 41134269)
-
(2005)
Diabetes
, vol.54
, Issue.8
, pp. 2404-2414
-
-
Kitabchi, A.E.1
-
20
-
-
77955468245
-
Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes
-
Kayaniyil S, Vieth R, Retnakaran R, et al., Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 2010; 33: 1379-81.
-
(2010)
Diabetes Care
, vol.33
, pp. 1379-1381
-
-
Kayaniyil, S.1
Vieth, R.2
Retnakaran, R.3
-
21
-
-
70549111807
-
Evaluation of proposed oral disposition index measures in relation to the actual disposition index
-
Retnakaran R, Qi Y, Goran MI, Hamilton JK,. Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med 2009; 26: 1198-203.
-
(2009)
Diabet Med
, vol.26
, pp. 1198-1203
-
-
Retnakaran, R.1
Qi, Y.2
Goran, M.I.3
Hamilton, J.K.4
-
22
-
-
0036318476
-
Accurate assessment of β-cell function: The hyperbolic correction
-
Bergman RN, Ader M, Huecking K, Van Citters G,. Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 2002; 51 (Suppl 1): S212-20. (Pubitemid 34761518)
-
(2002)
Diabetes
, vol.51
, Issue.SUPPL.
-
-
Bergman, R.N.1
Ader, M.2
Huecking, K.3
Van Citters, G.4
-
23
-
-
12844265257
-
Initiating insulin therapy in type 2 diabetes: A comparison of biphasic and basal insulin analogs
-
DOI 10.2337/diacare.28.2.260
-
Raskin P, Allen E, Hollander P, et al., Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs. Diabetes Care 2005; 28: 260-5. (Pubitemid 40170923)
-
(2005)
Diabetes Care
, vol.28
, Issue.2
, pp. 260-265
-
-
Raskin, P.1
Allen, E.2
Hollander, P.3
Lewin, A.4
Gabbay, R.A.5
Hu, P.6
Bode, B.7
Garber, A.8
-
24
-
-
14844360413
-
Combined therapy with insulin lispro mix 75/25 plus metformin or insulin glargine plus metformin: A 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy
-
DOI 10.1016/j.clinthera.2004.12.015
-
Malone JK, Kerr LF, Campaigne BN, et al., Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy. Clin Ther 2004; 26: 2034-44. (Pubitemid 40353613)
-
(2004)
Clinical Therapeutics
, vol.26
, Issue.12
, pp. 2034-2044
-
-
Malone, J.K.1
Kerr, L.F.2
Campaigne, B.N.3
Sachson, R.A.4
Holcombe, J.H.5
-
25
-
-
33646014162
-
Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study)
-
Garber AJ, Wahlen J, Wahl T, et al., Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study). Diabetes Obes Metab 2006; 8: 58-66.
-
(2006)
Diabetes Obes Metab
, vol.8
, pp. 58-66
-
-
Garber, A.J.1
Wahlen, J.2
Wahl, T.3
-
26
-
-
58149203398
-
Biphasic insulin aspart 30 in the treatment of elderly patients with type 2 diabetes: A subgroup analysis of the PRESENT Korea NovoMixstudy
-
Jang HC, Lee SR, Vaz JA,. Biphasic insulin aspart 30 in the treatment of elderly patients with type 2 diabetes: a subgroup analysis of the PRESENT Korea NovoMixstudy. Diabetes Obes Metab 2009; 11: 20-6.
-
(2009)
Diabetes Obes Metab
, vol.11
, pp. 20-26
-
-
Jang, H.C.1
Lee, S.R.2
Vaz, J.A.3
-
27
-
-
77955093018
-
Evaluation of error levels in hemoglobin A1c and glycated albumin in type 2 diabetic patients due to inter-individual variability
-
Tahara Y, Shima K,. Evaluation of error levels in hemoglobin A1c and glycated albumin in type 2 diabetic patients due to inter-individual variability. Diabetes Res Clin Pract 2010; 89: 115-20.
-
(2010)
Diabetes Res Clin Pract
, vol.89
, pp. 115-120
-
-
Tahara, Y.1
Shima, K.2
-
28
-
-
33947605228
-
Comparison of Glycated Albumin (GA) and Glycated Hemoglobin (HbA1c) in type 2 diabetic patients: Usefulness of GA for evaluation of short-term changes in glycemic control
-
DOI 10.1507/endocrj.K06-103
-
Takahashi S, Uchino H, Shimizu T, et al., Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Endocr J 2007; 54: 139-44. (Pubitemid 46481682)
-
(2007)
Endocrine Journal
, vol.54
, Issue.1
, pp. 139-144
-
-
Takahashi, S.1
Uchino, H.2
Shimizu, T.3
Kanazawa, A.4
Tamura, Y.5
Sakai, K.6
Watada, H.7
Hirose, T.8
Kawamori, R.9
Tanaka, Y.10
-
29
-
-
75149140141
-
Glycated albumin and glycated hemoglobin are influenced differently by endogenous insulin secretion in patients with type 2 diabetes
-
Koga M, Murai J, Saito H, Kasayama S,. Glycated albumin and glycated hemoglobin are influenced differently by endogenous insulin secretion in patients with type 2 diabetes. Diabetes Care 2010; 33: 270-2.
-
(2010)
Diabetes Care
, vol.33
, pp. 270-272
-
-
Koga, M.1
Murai, J.2
Saito, H.3
Kasayama, S.4
-
30
-
-
46749094241
-
Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes
-
DOI 10.1507/endocrj.K07E-089
-
Yoshiuchi K, Matsuhisa M, Katakami N, et al., Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocr J 2008; 55: 503-7. (Pubitemid 351949744)
-
(2008)
Endocrine Journal
, vol.55
, Issue.3
, pp. 503-507
-
-
Yoshiuchi, K.1
Matsuhisa, M.2
Katakami, N.3
Nakatani, Y.4
Sakamoto, K.5
Matsuoka, T.6
Umayahara, Y.7
Kosugi, K.8
Kaneto, H.9
Yamasaki, Y.10
Hori, M.11
-
31
-
-
79960253676
-
Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients
-
Lee EY, Lee BY, Kim D, et al., Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients. Acta Diabetol 2011; 48: 167-72.
-
(2011)
Acta Diabetol
, vol.48
, pp. 167-172
-
-
Lee, E.Y.1
Lee, B.Y.2
Kim, D.3
|